FIRST Entreprise
Supports Walloon companies through FIRST Entreprise to hire researchers for early innovation work.
FIRST Entreprise is a continuous, rolling grant from SPW Recherche that subsidizes Walloon companies hiring a researcher for a 12-to-24-month industrial research project combined with a mandatory training placement at a recognised research centre. Applications are accepted year-round through a guichet system and SPW Recherche guarantees a funding decision within three months of receiving a complet…
Rolling researcher-hire subsidy for Walloon companies employing a researcher for 12–24 months of industrial research combined with a mandatory training placement in a recognized research centre, with a three-month decision guarantee.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
BudgetGrant Financials and Co-Funding Evidence: Examples for Startup Applications
See examples of grant financials, match funding evidence, co-funding tables, accountant letters, investor commitments, and budget-to-work-plan checks.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
More from SPW Recherche
All grants from this funder →Eureka Lightweighting Call — Walloon Partner Share
🇧🇪SPW Recherche · Belgium
Funds Walloon companies in international collaborative research developing innovative lightweighting technologies.
Win4Doc (Seed)
🇧🇪SPW Recherche · Belgium
Funds Walloon companies hiring doctoral researchers through a programme sharing salary and project support.
Win4SpinOff
🇧🇪SPW Recherche · Belgium
Supports Walloon university spin-off formation through a start-up pathway from concept launch to commercialization planning.
Win2Wal — Call (Appel)
🇧🇪SPW Recherche · Belgium
Supports collaboration between Walloon universities and firms through a regional innovation grant for joint development.
Win4Company — R&D Aid
🇧🇪SPW Recherche · Belgium
Funds Walloon industrial teams through a regional programme for research and experimental development projects.
Similar grants
Browse the directory →Cancer Mission: First-in-Human Trials for Rare Cancers
🇪🇺European Commission · European Union
Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.
Cancer Mission: Functional Genomics for New Treatments
🇪🇺European Commission · European Union
Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.
Personalised approaches to reduce risks from adverse drug reactions due to multiple medications
🇪🇺European Commission · European Union
Funds safer medication management using biomarkers, clinical data and decision support.
Eureka Network Projects — Permanent
🇪🇺EUREKA · Global / Multinational
Offers open access collaboration through Eureka Network Projects so small enterprises can join international innovation groups.
MSCA Postdoctoral Fellowships — ISERD)
🇪🇺ISERD · Israel
Supports internationally mobile postdoctoral researchers placed in Israeli institutions to build independent research careers through EU mobility fellowships.
Pre-Commercial Procurement for Cancer Care
🇪🇺European Commission · European Union
Funds €8–10M procurer consortia to bring affordable cancer technologies, devices and medicines from tender to patient benefit.